127 related articles for article (PubMed ID: 28745666)
1. [Detection of effective treatment of amnestic mild cognitive impairement with cereton by testing of lipids markers].
Alesenko AV; Gavrilova SI; Gutner UA; Lebedeva AO; Shupik MA; Kolykhalov IV; Ponomareva EV; Selezneva ND; Fedorova YB
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):21-27. PubMed ID: 28745666
[TBL] [Abstract][Full Text] [Related]
2. Ceramide metabolism is affected by obesity and diabetes in human adipose tissue.
Błachnio-Zabielska AU; Pułka M; Baranowski M; Nikołajuk A; Zabielski P; Górska M; Górski J
J Cell Physiol; 2012 Feb; 227(2):550-7. PubMed ID: 21437908
[TBL] [Abstract][Full Text] [Related]
3. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
Modrak DE
Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
[TBL] [Abstract][Full Text] [Related]
4. Aerobic training in rats increases skeletal muscle sphingomyelinase and serine palmitoyltransferase activity, while decreasing ceramidase activity.
Błachnio-Zabielska A; Zabielski P; Baranowski M; Gorski J
Lipids; 2011 Mar; 46(3):229-38. PubMed ID: 21181285
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy and safety of choline alfoscerate in the treatment of late-onset cognitive impairment].
Gavrilova SI; Kolykhalov IV; Ponomareva EV; Fedorova YB; Selezneva ND
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):45-53. PubMed ID: 29927403
[TBL] [Abstract][Full Text] [Related]
6. Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue.
Kolak M; Gertow J; Westerbacka J; Summers SA; Liska J; Franco-Cereceda A; Orešič M; Yki-Järvinen H; Eriksson P; Fisher RM
Lipids Health Dis; 2012 Sep; 11():115. PubMed ID: 22974251
[TBL] [Abstract][Full Text] [Related]
7. Implication of sphingomyelin/ceramide molar ratio on the biological activity of sphingomyelinase.
Boulgaropoulos B; Amenitsch H; Laggner P; Pabst G
Biophys J; 2010 Jul; 99(2):499-506. PubMed ID: 20643068
[TBL] [Abstract][Full Text] [Related]
8. [Activity of the sphingomyelin cycle enzymes and concentration of products of sphingomyelin degradation in the rat liver in the course of acute toxic hepatitis].
Serebrov VIu; Kuz'menko DI; Burov PG; Sapugol'tseva OB
Biomed Khim; 2010; 56(2):283-9. PubMed ID: 21341516
[TBL] [Abstract][Full Text] [Related]
9. Fingolimod Affects Transcription of Genes Encoding Enzymes of Ceramide Metabolism in Animal Model of Alzheimer's Disease.
Jęśko H; Wencel PL; Wójtowicz S; Strosznajder J; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2020 Jun; 57(6):2799-2811. PubMed ID: 32356173
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Novel Acid Sphingomyelinase Activity Associated with Recombinant Human Acid Ceramidase.
He X; Schuchman EH
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002305
[TBL] [Abstract][Full Text] [Related]
11. A lipid analogue that inhibits sphingomyelin hydrolysis and synthesis, increases ceramide, and leads to cell death.
Darroch PI; Dagan A; Granot T; He X; Gatt S; Schuchman EH
J Lipid Res; 2005 Nov; 46(11):2315-24. PubMed ID: 16150832
[TBL] [Abstract][Full Text] [Related]
12. Effect of acute exercise and training on metabolism of ceramide in the heart muscle of the rat.
Dobrzyń A; Knapp M; Górski J
Acta Physiol Scand; 2004 Jul; 181(3):313-9. PubMed ID: 15196092
[TBL] [Abstract][Full Text] [Related]
13. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane.
Holopainen JM; Subramanian M; Kinnunen PK
Biochemistry; 1998 Dec; 37(50):17562-70. PubMed ID: 9860872
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
15. Content and structure of ceramide and sphingomyelin and sphingomyelinase activity in mouse hepatoma-22.
Rylova SN; Somova OG; Zubova ES; Dudnik LB; Kogtev LS; Kozlov AM; Alesenko AV; Dyatlovitskaya EV
Biochemistry (Mosc); 1999 Apr; 64(4):437-41. PubMed ID: 10231598
[TBL] [Abstract][Full Text] [Related]
16. Resynthesis of sphingomyelin from plasma-membrane phosphatidylcholine in BHK cells treated with Staphylococcus aureus sphingomyelinase.
Allan D; Quinn P
Biochem J; 1988 Sep; 254(3):765-71. PubMed ID: 2848498
[TBL] [Abstract][Full Text] [Related]
17. Effect of exercise duration on the key pathways of ceramide metabolism in rat skeletal muscles.
Błachnio-Zabielska A; Baranowski M; Zabielski P; Górski J
J Cell Biochem; 2008 Oct; 105(3):776-84. PubMed ID: 18680146
[TBL] [Abstract][Full Text] [Related]
18. Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies.
Abusukhun M; Winkler MS; Pöhlmann S; Moerer O; Meissner K; Tampe B; Hofmann-Winkler H; Bauer M; Gräler MH; Claus RA
Front Immunol; 2021; 12():784989. PubMed ID: 34987511
[TBL] [Abstract][Full Text] [Related]
19. Exercise and training effects on ceramide metabolism in human skeletal muscle.
Helge JW; Dobrzyn A; Saltin B; Gorski J
Exp Physiol; 2004 Jan; 89(1):119-27. PubMed ID: 15109217
[TBL] [Abstract][Full Text] [Related]
20. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk.
Samad F; Hester KD; Yang G; Hannun YA; Bielawski J
Diabetes; 2006 Sep; 55(9):2579-87. PubMed ID: 16936207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
